Screener
Bio-Rad Laboratories BIO Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Net sales | $592.1 | $585.4 |
| Cost of goods sold | 282.7 | 279.4 |
| Gross profit | 309.4 | 306.0 |
| Selling, general and administrative expense | 212.4 | 208.8 |
| Research and development expense | 62.9 | 73.5 |
| Income from operations | 34.1 | 23.7 |
| Interest expense | 12.3 | 12.0 |
| Foreign currency exchange gains, net | (2.4) | (2.7) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's total revenue?
- Bio-Rad Laboratories (BIO) reported total revenue of $592.1M in Q1 2026.
- How has Bio-Rad Laboratories's total revenue changed year-over-year?
- Bio-Rad Laboratories's total revenue increased by 1.1% year-over-year, from $585.4M to $592.1M.
- What is the long-term trend for Bio-Rad Laboratories's total revenue?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's total revenue has grown at a -3.0% compound annual growth rate (CAGR), from $2.92B to $2.58B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Bio-Rad Laboratories's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude